highly significantp < 0.0001
Group differences were highly significant ( p < 0.0001), and the scoring system was applicable to younger patients (<60 years of age) and patients with advanced or localized stages of the disease.
Group differences were highly significant ( p < 0.0001), and the scoring system was applicable to younger patients (<60 years of age) and patients with advanced or localized stages of the disease.
In addition, MYC/BCL2 double expression showed a trend toward significance with changes in OS probability ( p = 0.082; Supporting information Figure S3A ) and a significantly greater influence on PFS ( p = 0.0417; Supporting information Figure S3B ).
COO subtypes differed significantly in their OS probability (p = 0.0182; Supporting information Figure S2A ) and showed a nonsignificant trend in the analysis of PFS ( p = 0.095; Supporting information Figure S2B ).